Leadership

Shaping the field through conference presentations, scientific committee chairs, and collaborative international leadership.

Scientific Presentation in the Mechanism-Based Therapeutics for Developmental and Acquired Epilepsy Session

  • Society for Neuroscience 2026
  • 2026 – 2026

Highlighting ongoing scientific research and presentation of "Corneal Kindled Alzheimer's Disease-Related Mice Address Mechanisms of and Preventative Treatments for Sudden Unexpected Death in Epilepsy"

Executive Committee - Translational and Clinical Pharmacology Division

  • American Society for Pharmacology and Experimental Therapeutics
  • 2026 – Present

Contribute to scientific programming for ASPET annual meeting, including supporting the Ray Fuller Award selection, poster abstract awards, and early career awardees.

Vice Chair - Translational Research Committee

  • American Epilepsy Society
  • 2026 – Present

Developed scientific direction of the American Epilepsy Society Annual Meeting Translational Research Committee Symposium and moderated conference presentations of invited speakers. This session was CME eligible and included speakers from basic and clinical sciences, providing educational impact for an estimated 250 meeting attendees from patient advocacy organizations, industry, academia, and government.

Preclinical Precision Medicine Task Force - Chair

  • International League Against Epilepsy
  • 2025 – Present

Integrating cutting-edge research on epilepsy mechanisms to translate fundamental insights into patient-tailored preclinical interventions, refine experimental models to better reflect disease complexity, and foster innovation that bridges basic science and clinical application for more effective, individualized epilepsy treatment